Mediator, pg/ml | LLD | HIV uninfected na = 19 | HIV infected n = 22 | p valueb |
---|---|---|---|---|
Median (IQR) | Median (IQR) | |||
Pro-inflammatory | ||||
IL-23 | 8.0 | 194 (151–408) | 53 (29–103) | < 0.001 |
IL-17α | 0.7 | 7 (5–12) | 2 (1–4) | < 0.001 |
IL-12(p70) | 0.5 | 5 (4–8) | 2 (1–2) | < 0.001 |
TNF-α | 0.4 | 8 (7–10) | 6 (5–7) | < 0.001 |
IL-1β | 0.5 | 5 (5–7) | 2 (1–5) | 0.25 |
IL-6 | 0.2 | 9 (6–30) | 6 (2–40) | 0.25 |
Chemotactic | ||||
IL-8/CXCL8 | 0.3 | 9 (8–13) | 36 (15–361) | < 0.001 |
CX3CL1 | 18.0 | 333 (205–459) | 71 (48–120) | < 0.001 |
CCL20 | 0.6 | 22 (19–27) | 15 (13–20) | < 0.002 |
CXCL11 | 1.5 | 157 (93–236) | 45 (24–85) | < 0.001 |
CCL3 | 0.3 | 30 (25–34) | 13 (10–57) | 0.25 |
CCL4 | 1.0 | 33 (27–46) | 13 (7–56) | 0.02 |
Immunoregulatory | ||||
IFN-γ | 0.6 | 21 (17–32) | 12 (11–17) | < 0.001 |
IL-7 | 0.4 | 14 (10–18) | 7 (5–10) | < 0.001 |
IL-2 | 0.5 | 0 (0–5) | 2 (1–3) | 0.09 |
IL-21 | 0.3 | 3 (1–5) | 2 (1–4) | 1.0 |
Th2 | ||||
IL-4 | 1.8 | 136 (84–162) | 14 (8-19) | < 0.001 |
IL-5 | 0.5 | 4 (2–5) | 2 (1-2) | < 0.001 |
IL-10 | 1.5 | 19 (8–23) | 5 (4-9) | < 0.001 |
GM-CSF | 1.2 | 282 (132–358) | 37 (21-51) | < 0.001 |
IL-13 | 0.3 | 10 (5–16) | 5 (4-8) | 0.01 |